Table 2.
Baseline clinical and laboratory information of patients.
| Characteristics | Frequency | Percentage | ||
|---|---|---|---|---|
| Past opportunistic infection | Herpes zoster | 16 | 18.2 | |
| Candidiasis (oral and esophageal) | 25 | 28.4 | ||
| Pneumocystis pneumonia | 18 | 20.5 | ||
| Past TB test | Positive | 27 | 11.4 | |
| Negative | 210 | 88.6 | ||
| Diarrhea | 11 | 12.5 | ||
| Others | 18 | 20.3 | ||
| Functional status | Working | 227 | 95.8 | |
| Ambulatory | 10 | — | ||
| WHO clinical staging | Stage I | 146 | 61.6 | |
| Stage II | 43 | 18.1 | ||
| Stage III and IV | 48 | 20.3 | ||
| CD4 counts | <350 | 74 | 31.2 | |
| ≥350 | 163 | 68.8 | ||
| BMI (kg/m2) | <18.5 | 66 | 27.8 | |
| 18.5–24.9 | 123 | 51.9 | ||
| ≥25.0 | 48 | 20.3 | ||